Application | Comment | Organism |
---|---|---|
medicine | NQO1 guards against oxidative stress and carcinogenesis and stabilizes p53, a homozygous common missense variant, NQO1*2, P187S that disables NQO1 predicts poor survival of women with breast cancer, NQO1 deficiency implicates cancer progression and treatment resistance to epirubicin, the NQO1 status is important for the response to epirubicin, ionizing radiation or 5-FU is not, NQO1 genotype is a prognostic and predictive marker for breast cancer | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | P187S protein undergoes rapid turnover via the ubiquitin proteasomal pathway, cells with the homozygous NQO1*2 genotype have no measurable NQO1 activity | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
breast cancer patients | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
B-lymphoblastoid cell line | wild-type p53immortalized B-cell lymphoblasts from individuals with heterozygous NQO1; homozygous NQO1+/- and missing NQO1, LBL51 | Homo sapiens | - |
leukocyte | for genotyping | Homo sapiens | - |
MCF-7 cell | wild-type p53 breast cancer cell lines MCF7 transfected with MCF7-NQO1 to overexpress NQO1, MCF7-SUP8 to knockdown NQO1 | Homo sapiens | - |
U2-OS cell | p53 mutant MDA-MB-157 and MDAMB-231, dominant negative p53 | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
NADPH:quinone oxidoreductase 1 | wild type NQO1, variant NQO1*2 induces an amino acid change P187S | Homo sapiens |
NQO1 | - |
Homo sapiens |